Affinity Crystallography: A New Approach to Extracting High-Affinity Enzyme Inhibitors from Natural Extracts
Autor: | Gary D. Brayer, Labros G. Meimetis, Ping Cheng, Ivan Villanueva, Tina M. Bott, Simon Law, Dieter Brömme, Adeleke Aguda, Vincent Lavallee, Nham T. Nguyen, Jadwiga Kaleta, David E. Williams, Julian Davies, Raymond J. Andersen |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Lichens Chemical structure Cathepsin K Pharmaceutical Science Biology Crystallography X-Ray 01 natural sciences Analytical Chemistry 03 medical and health sciences chemistry.chemical_compound Drug Discovery Hydrolase Potency Antipain Nuclear Magnetic Resonance Biomolecular Pharmacology chemistry.chemical_classification Biological Products Natural product British Columbia Molecular Structure 010405 organic chemistry Drug discovery Organic Chemistry Combinatorial chemistry 0104 chemical sciences Crystallography 030104 developmental biology Enzyme Complementary and alternative medicine chemistry Biochemistry Molecular Medicine Peptides |
Zdroj: | Journal of natural products. 79(8) |
ISSN: | 1520-6025 |
Popis: | Natural products are an important source of novel drug scaffolds. The highly variable and unpredictable timelines associated with isolating novel compounds and elucidating their structures have led to the demise of exploring natural product extract libraries in drug discovery programs. Here we introduce affinity crystallography as a new methodology that significantly shortens the time of the hit to active structure cycle in bioactive natural product discovery research. This affinity crystallography approach is illustrated by using semipure fractions of an actinomycetes culture extract to isolate and identify a cathepsin K inhibitor and to compare the outcome with the traditional assay-guided purification/structural analysis approach. The traditional approach resulted in the identification of the known inhibitor antipain (1) and its new but lower potency dehydration product 2, while the affinity crystallography approach led to the identification of a new high-affinity inhibitor named lichostatinal (3). The structure and potency of lichostatinal (3) was verified by total synthesis and kinetic characterization. To the best of our knowledge, this is the first example of isolating and characterizing a potent enzyme inhibitor from a partially purified crude natural product extract using a protein crystallographic approach. |
Databáze: | OpenAIRE |
Externí odkaz: |